Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Modified release tranexamic acid formulation

Modified release tranexamic acid formulation

US Patent 9387178 · Granted Jul 12, 2016

Estimated economic value: $776,118,000 ⓘ

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Controlled-release tablets, method of making, and method of use thereof2024
Oral dosage forms of ibrutinib2022
Osmotic dosage forms comprising deutetrabenazine and methods of use thereof2022
Modified release tranexamic acid formulation2013
Modified release tranexamic acid formulation2013
Extended release formulation of levetiracetam2010
Extended release formulation of venlafaxine hydrochloride2010